| manager |
|
| language |
- |
| license |
- |
| created at |
2017-12-21 11:07:16 UTC |
| updated at |
2017-12-21 12:22:32 UTC |
|
2 layers
|
143,100 entries
|
There is 0 pattern entry.
|
Pharmacology Written Summary
|
CONC:NCI_FDA |
|
|
Plasma Protein Binding Study Reports And Related Information
|
CONC:NCI_FDA |
|
|
Population PK Study Reports And Related Information
|
CONC:NCI_FDA |
|
|
Drug Product: Post-Approval Stability Protocol And Stability Commitment
|
CONC:NCI_FDA |
|
|
Drug Substance: Post Approval Stability Protocol And Stability Commitment
|
CONC:NCI_FDA |
|
|
Pre IND Correspondence
|
CONC:NCI_FDA |
|
|
Drug Substance: Process Validation And/Or Evaluation
|
CONC:NCI_FDA |
|
|
Promotional Material Document
|
CONC:NCI_FDA |
|
|
PROMOTIONAL MATERIALS
|
CONC:NCI_FDA |
|
|
Promotional Material
|
CONC:NCI_FDA |
|
|
Proposal For Written Agreement
|
CONC:NCI_FDA |
|
|
Proposed Pediatric Study Request And Amendments
|
CONC:NCI_FDA |
|
|
Public Disclosure Statement For Exception From Informed Consent For Research
|
CONC:NCI_FDA |
|
|
Quality Information Amendment
|
CONC:NCI_FDA |
|
|
Quality Overall Summary
|
CONC:NCI_FDA |
|
